dapsone has been researched along with Communicable Diseases in 3 studies
Communicable Diseases: An illness caused by an infectious agent or its toxins that occurs through the direct or indirect transmission of the infectious agent or its products from an infected individual or via an animal, vector or the inanimate environment to a susceptible animal or human host.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Le Roux-Villet, C | 1 |
| Prost-Squarcioni, C | 1 |
| Alexandre, M | 1 |
| Caux, F | 1 |
| Pascal, F | 1 |
| Doan, S | 1 |
| Brette, MD | 1 |
| Soued, I | 1 |
| Gabison, É | 1 |
| Aucouturier, F | 1 |
| Letestu, R | 1 |
| Laroche, L | 1 |
| Bachelez, H | 1 |
| COOPER, JR | 1 |
| Rees, RJ | 1 |
| Weddell, AG | 1 |
3 other studies available for dapsone and Communicable Diseases
| Article | Year |
|---|---|
Rituximab for patients with refractory mucous membrane pemphigoid.
Topics: Adolescent; Adult; Agammaglobulinemia; Aged; Aged, 80 and over; Antibodies, Monoclonal, Murine-Deriv | 2011 |
LEPROSY. MYCOBACTERIAL NEURODERMATOSIS: REPORT OF A CASE.
Topics: Clinical Laboratory Techniques; Communicable Diseases; Dapsone; Drug Therapy; Female; Humans; Labora | 1965 |
Transmission of human leprosy to the mouse and its clinical implications.
Topics: Animals; Communicable Diseases; Dapsone; Disease Models, Animal; Drug Resistance, Microbial; Hindlim | 1970 |